Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease - PubMed (original) (raw)
Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease
A M Cataldo et al. Proc Natl Acad Sci U S A. 1991.
Erratum in
- Proc Natl Acad Sci U S A 1992 Mar 15;89(6):2509
Abstract
beta-Amyloid formation requires multiple abnormal proteolytic cleavages of amyloid precursor protein (APP), including one within its intramembrane domain. Lysosomes, which contain a wide variety of proteases (cathepsins) and other acid hydrolases, are major sites for the turnover of membrane proteins and other cell constituents. Using immunocytochemistry, immunoelectron microscopy, and enzyme histochemistry, we studied the expression and cellular distributions of 10 lysosomal hydrolases, including 4 cathepsins, in neocortex from patients with Alzheimer disease and control (non-Alzheimer-disease) individuals. In control brains, acid hydrolases were localized exclusively to intracellular lysosome-related compartments, and 8 of the 10 enzymes predominated in neurons. In Alzheimer disease brains, strongly immunoreactive lysosomes and lipofuscin granules accumulated markedly in the perikarya and proximal dendrites of many cortical neurons, some of which were undergoing degeneration. More strikingly, these same hydrolases were present in equally high or higher levels in senile plaques in Alzheimer disease, but they were not found extracellularly in control brains, including those from Parkinson or Huntington disease patients. At the ultrastructural level, hydrolase immunoreactivity in senile plaques was localized to extracellular lipofuscin granules similar in morphology to those within degenerating neurons. Two cathepsins that were undetectable in neurons were absent from senile plaques. These results show that lysosome function is altered in cortical neurons in Alzheimer disease. The presence of a broad spectrum of acid hydrolases in senile plaques indicates that lysosomes and their contents may be liberated from cells, principally neurons and their processes, as they degenerate. Because cathepsins can cleave polypeptide sites on APP relevant for beta-amyloid formation, their abnormal extracellular localization and dysregulation in Alzheimer disease can account for the multiple hydrolytic events in beta-amyloid formation. The actions of membrane-degrading acid hydrolases could also explain how the intramembrane portion of APP containing the C terminus of beta-amyloid becomes accessible to proteases.
Similar articles
- Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.
Cataldo AM, Nixon RA. Cataldo AM, et al. Proc Natl Acad Sci U S A. 1990 May;87(10):3861-5. doi: 10.1073/pnas.87.10.3861. Proc Natl Acad Sci U S A. 1990. PMID: 1692625 Free PMC article. - Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease.
Cataldo AM, Hamilton DJ, Nixon RA. Cataldo AM, et al. Brain Res. 1994 Mar 21;640(1-2):68-80. doi: 10.1016/0006-8993(94)91858-9. Brain Res. 1994. PMID: 8004466 - Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin.
Cataldo AM, Thayer CY, Bird ED, Wheelock TR, Nixon RA. Cataldo AM, et al. Brain Res. 1990 Apr 16;513(2):181-92. doi: 10.1016/0006-8993(90)90456-l. Brain Res. 1990. PMID: 2350688 - The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review.
Bernstein HG, Kirschke H, Wiederanders B, Pollak KH, Zipress A, Rinne A. Bernstein HG, et al. Mol Chem Neuropathol. 1996 Apr;27(3):225-47. doi: 10.1007/BF02815106. Mol Chem Neuropathol. 1996. PMID: 9147410 Review. - Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.
Glabe C. Glabe C. J Mol Neurosci. 2001 Oct;17(2):137-45. doi: 10.1385/JMN:17:2:137. J Mol Neurosci. 2001. PMID: 11816787 Review.
Cited by
- Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques.
Gowrishankar S, Yuan P, Wu Y, Schrag M, Paradise S, Grutzendler J, De Camilli P, Ferguson SM. Gowrishankar S, et al. Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):E3699-708. doi: 10.1073/pnas.1510329112. Epub 2015 Jun 29. Proc Natl Acad Sci U S A. 2015. PMID: 26124111 Free PMC article. - Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.
Zhan X, Jickling GC, Ander BP, Stamova B, Liu D, Kao PF, Zelin MA, Jin LW, DeCarli C, Sharp FR. Zhan X, et al. J Alzheimers Dis. 2015;44(4):1213-29. doi: 10.3233/JAD-142013. J Alzheimers Dis. 2015. PMID: 25697841 Free PMC article. - Arf6 controls beta-amyloid production by regulating macropinocytosis of the Amyloid Precursor Protein to lysosomes.
Tang W, Tam JH, Seah C, Chiu J, Tyrer A, Cregan SP, Meakin SO, Pasternak SH. Tang W, et al. Mol Brain. 2015 Jul 14;8:41. doi: 10.1186/s13041-015-0129-7. Mol Brain. 2015. PMID: 26170135 Free PMC article. - Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain.
Liao G, Yao Y, Liu J, Yu Z, Cheung S, Xie A, Liang X, Bi X. Liao G, et al. Am J Pathol. 2007 Sep;171(3):962-75. doi: 10.2353/ajpath.2007.070052. Epub 2007 Jul 13. Am J Pathol. 2007. PMID: 17631520 Free PMC article. - RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA, Race B, Williams K, Striebel J, Chesebro B. Carroll JA, et al. Mol Brain. 2020 May 7;13(1):71. doi: 10.1186/s13041-020-00610-8. Mol Brain. 2020. PMID: 32381108 Free PMC article.
References
- Nature. 1989 Oct 12;341(6242):546-9 - PubMed
- J Histochem Cytochem. 1965 Jul-Aug;13(6):520-3 - PubMed
- EMBO J. 1988 Apr;7(4):949-57 - PubMed
- Proc Natl Acad Sci U S A. 1986 Jun;83(11):4044-8 - PubMed
- J Hirnforsch. 1989;30(3):313-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases